Sobi Pays $100m Upfront For Selecta Gout Drug

Set To Challenge Horizon’s Krystexxa

 
• By Kevin Grogan
  
Gout
The refractory gout market is worth $1bn in the US alone • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business